Implementing Antibiotic Stewardship Strategies to Improve Treatment of Newborns with Suspected Early-Onset Sepsis
A Study in Dutch Hospitals Using EOS Calculator, PCT-Guided Therapy, and IV-to-Oral Switch
Led by Franciscus Gasthuis · Updated on 2025-09-19
55000
Participants Needed
11
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the implementation of three evidence-based antibiotic stewardship strategies to improve treatment for neonates suspected of early-onset sepsis in Dutch hospitals. These strategies include the early-onset sepsis EOS calculator, procalcitonin PCT-guided therapy, and intravenous-to-oral switch therapy. While effective and safe, these practices are not yet used in all hospitals, leading to differences in clinical care. The study aims to assess the impact of actively implementing this bundle of interventions using a multicomponent approach across multiple centers.
The study uses a prospective, multicenter, non-randomized pre-post design to compare clinical outcomes before and after implementing the stewardship strategies. Hospitals will collect retrospective clinical data on neonates from 12 months before and 12 months after the implementation period. Qualitative data will also be gathered through focus groups, interviews, and surveys to understand the effectiveness of the implementation methods.
Participants are neonates born at 34 weeks gestation or later who are 0 to 3 days old at enrollment. Clinical data will be anonymized and analyzed to measure outcomes such as days on antibiotic therapy. The research team will monitor both clinical and implementation results to evaluate how the stewardship strategies affect care. The study is expected to run through June 2026 with ongoing observation of treatment practices and outcomes.
CONDITIONS
Brief Title
Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis
Research Team
L
Liesanne E. J. Van Veen, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
Long-term Monitoring
Duration - 12 months pre-implementation and 12 months post-implementation
Participants who undergo routine care are observed to collect data on antibiotic therapy over time.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Implementation strategy for an antibiotic stewardship bundle to promote optimal treatment choices in neonates with suspected early-onset sepsis (Protect-Neo): a study protocol for a multicentre, prospective interrupted time series and before-after study.
Liesanne E J van Veen, Gerdien A Tramper-Stranders, Niek B Achten...
Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).
Martin Stocker, Wendy van Herk, Salhab El Helou...
Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysis.
Niek B Achten, Claus Klingenberg, William E Benitz...
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
Fleur M Keij, René F Kornelisse, Nico G Hartwig...